The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  November 2018 Next
  • Bürgenstock Conference 2019

    May 5-9, 2019   Brunnen, Switzerland

    The ‘SCS Conference on Stereochemistry’, better known as ‘Bürgenstock Conference’, is an outstanding international chemistry meeting of high scientific quality, with an optimal setting for intense inter-disciplinary discussion.

    Stereochemistry is the principle underlying our understanding of the processes of life and the properties of matter at the molecular level. It is a key element not only in all chemical disciplines, but also in modern molecular biology, molecular medicine, biophysics, and material design. Accordingly, the ‘Bürgenstock Conference’ has grown over the years into a multi-disciplinary conference where frontier science is being discussed. Lectures cover many areas of chemistry and relevant highlights from neighboring disciplines.

    According to its long tradition, the 54th Bürgenstock Conference 2019 will again be interdisciplinary, covering many areas of chemistry in its main body, but allowing also for relevant highlights from neighboring disciplines, with due focus on structural and mechanistic aspects in all contributions.

    For more information please contact: info@scg.ch

M T W T F S S
29 30 31 01 02 03 04
05 06 07 08 09 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 01 02
All events   |  Future events

Job portal

There are currently no jobs available

Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

Follow us on Instagram

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck